482 related articles for article (PubMed ID: 28662299)
1. Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study.
Hisada R; Kato M; Sugawara E; Fujieda Y; Oku K; Bohgaki T; Amengual O; Yasuda S; Atsumi T
J Thromb Haemost; 2017 Sep; 15(9):1782-1787. PubMed ID: 28662299
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria.
Demetrio Pablo R; Muñoz P; López-Hoyos M; Calvo V; Riancho L; Martínez-Taboada VM
Med Clin (Barc); 2017 May; 148(9):394-400. PubMed ID: 28153433
[TBL] [Abstract][Full Text] [Related]
3. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
[TBL] [Abstract][Full Text] [Related]
4. Clinical profiles and risk assessment in patients with antiphospholipid antibodies.
Kato M; Hisada R; Atsumi T
Expert Rev Clin Immunol; 2019 Jan; 15(1):73-81. PubMed ID: 30381978
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies.
Kim KJ; Baek IW; Yoon CH; Kim WU; Cho CS
Br J Haematol; 2013 Jun; 161(5):706-714. PubMed ID: 23530551
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.
Bala MM; Paszek E; Lesniak W; Wloch-Kopec D; Jasinska K; Undas A
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012534. PubMed ID: 30004572
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events.
Otomo K; Atsumi T; Amengual O; Fujieda Y; Kato M; Oku K; Horita T; Yasuda S; Koike T
Arthritis Rheum; 2012 Feb; 64(2):504-12. PubMed ID: 21953404
[TBL] [Abstract][Full Text] [Related]
8. Length of exposure to antiphospholipid antibodies, rather than age, is a risk factor for thrombosis: a retrospective single-centre observational study.
Les I; Parraza N; Anaut P; Eguiluz S; Sánchez C; Preciado ME; Loza JÁ; Andía A
Rheumatol Int; 2018 Feb; 38(2):229-238. PubMed ID: 29124399
[TBL] [Abstract][Full Text] [Related]
9. Thrombocytopenia in high-risk patients with antiphospholipid syndrome.
Pontara E; Banzato A; Bison E; Cattini MG; Baroni G; Denas G; Calligaro A; Marson P; Tison T; Ruffatti A; Pengo V
J Thromb Haemost; 2018 Mar; 16(3):529-532. PubMed ID: 29316193
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study.
Pablo RD; Cacho PM; López-Hoyos M; Calvo-Río V; Riancho-Zarrabeitia L; Martínez-Taboada VM
Clin Rev Allergy Immunol; 2022 Apr; 62(2):354-362. PubMed ID: 34216367
[TBL] [Abstract][Full Text] [Related]
12. Calprotectin Impairs Platelet Survival in Patients With Primary Antiphospholipid Syndrome.
Hoy CK; NaveenKumar SK; Navaz SA; Sugur K; Yalavarthi S; Sarosh C; Smith T; Kmetova K; Chong E; Peters NF; Rysenga CE; Norman GL; Figueroa-Parra G; Nelson D; Girard J; Ahmed AZ; Schaefer JK; Gudjonsson JE; Kahlenberg JM; Madison JA; Knight JS; Crowson CS; Duarte-García A; Zuo Y
Arthritis Rheumatol; 2024 Jun; 76(6):928-935. PubMed ID: 38225923
[TBL] [Abstract][Full Text] [Related]
13. Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity.
Yelnik CM; Urbanski G; Drumez E; Sobanski V; Maillard H; Lanteri A; Morell-Dubois S; Caron C; Dubucquoi S; Launay D; Duhamel A; Hachulla E; Hatron PY; Lambert M
Lupus; 2017 Feb; 26(2):163-169. PubMed ID: 27432808
[TBL] [Abstract][Full Text] [Related]
14. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
[TBL] [Abstract][Full Text] [Related]
15. The first thrombotic event in purely obstetric antiphospholipid syndrome patients and in antiphospholipid antibody carriers: comparison of incidence and characteristics.
Tonello M; Calligaro A; Favaro M; Del Ross T; Veronese P; Salvan E; Gervasi MT; Ruffatti A
Arch Gynecol Obstet; 2021 Feb; 303(2):455-461. PubMed ID: 32880711
[TBL] [Abstract][Full Text] [Related]
16. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
[TBL] [Abstract][Full Text] [Related]
17. Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndrome.
Barbati C; Stefanini L; Colasanti T; Cipriano E; Celia A; Gabriele G; Vomero M; Ceccarelli F; Spinelli FR; Finucci A; Speziali M; Orso G; Margiotta DPE; Conti F; Violi F; Afeltra A; Valesini G; Alessandri C
Arthritis Res Ther; 2019 Jul; 21(1):161. PubMed ID: 31262358
[TBL] [Abstract][Full Text] [Related]
18. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
Mustonen P; Lehtonen KV; Javela K; Puurunen M
Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic Primary Antiphospholipid Syndrome: the profile of antibody positivity in patients from North India.
Ahluwalia J; Sreedharanunni S; Kumar N; Masih J; Bose SK; Varma N; Varma S; Singh S
Int J Rheum Dis; 2016 Sep; 19(9):903-12. PubMed ID: 25292011
[TBL] [Abstract][Full Text] [Related]
20. β
Serrano M; Martínez-Flores JA; Pérez D; García F; Cabrera-Marante O; Pleguezuelo D; Paz-Artal E; Morales JM; González E; Serrano A
Circulation; 2017 May; 135(20):1922-1934. PubMed ID: 28249878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
